Julian Maurer

Julian Maurer

UNVERIFIED PROFILE

Are you Julian Maurer?   Register this Author

Register author
Julian Maurer

Julian Maurer

Publications by authors named "Julian Maurer"

Are you Julian Maurer?   Register this Author

15Publications

282Reads

21Profile Views

Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors in vitro: Antitumoral Effects.

Cancers (Basel) 2020 Feb 4;12(2). Epub 2020 Feb 4.

Department of Internal Medicine 4, University-Hospital, Klinikum der Universitaet Muenchen, Ludwig-Maximilians-University of Munich, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12020345DOI Listing
February 2020

The Novel Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) Alone and in Dual-Targeting Approaches Demonstrates Antitumoral Efficacy in Neuroendocrine Tumors in vitro.

Neuroendocrinology 2018 23;106(1):58-73. Epub 2017 Feb 23.

Department of Internal Medicine II, Campus Grosshadern, University Hospital, Ludwig-Maximilians University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000463386DOI Listing
January 2019

The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance.

Endocr Relat Cancer 2018 10 12;25(10):893-908. Epub 2018 Jun 12.

Medizinische Klinik und Poliklinik IVInterdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM), Klinikum der Universität München (KUM), Ludwig-Maximilians-University, Munich, Germany

View Article

Download full-text PDF

Source
https://erc.bioscientifica.com/view/journals/erc/25/10/ERC-1
Publisher Site
http://dx.doi.org/10.1530/ERC-18-0159DOI Listing
October 2018

Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors.

Endocr Relat Cancer 2018 05 21;25(5):547-560. Epub 2018 Mar 21.

Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM), Klinikum der Universität München, Ludwig-Maximilians-University of Munich, Campus Grosshadern, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-17-0201DOI Listing
May 2018

The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells.

PLoS One 2017 25;12(5):e0178375. Epub 2017 May 25.

Department of Internal Medicine II, Campus Grosshadern, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System (GEPNET-KUM), University-Hospital, Ludwig-Maximilians-University of Munich, Bavaria, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0178375PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444855PMC
September 2017

Aspirin inhibits cell viability and mTOR downstream signaling in gastroenteropancreatic and bronchopulmonary neuroendocrine tumor cells.

World J Gastroenterol 2014 Aug;20(29):10038-49

Matilde Spampatti, George Vlotides, Gerald Spöttl, Julian Maurer, Burkhard Göke, Christoph J Auernhammer, Department of Internal Medicine II, University-Hospital Campus Grosshadern, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System (GEPNET-KUM), Ludwig-Maximilians-University of Munich, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v20.i29.10038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123333PMC
August 2014

Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells.

Int J Oncol 2013 Dec 4;43(6):1824-32. Epub 2013 Oct 4.

Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D‑81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2013.2130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834873PMC
December 2013